Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care Center at John Muir Health - Concord Campus
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Veterans Affairs Medical Center - Loma Linda (pettis)
Loma Linda, California, United States
- John Muir/mt. Diablo Comprehensive Cancer Center
Walnut Creek, California, United States
- Kaiser Permanente Medical Center - Walnut Creek
Walnut Creek, California, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Central Baptist Hospital
Lexington, Kentucky, United States
- Louisville Oncology at Norton Cancer Center
Louisville, Kentucky, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
Baltimore, Maryland, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Altru Cancer Center at Altru Hospital
Grand Forks, North Dakota, United States
- Natalie Warren Bryant Cancer Center at St. Francis Hospital
Tulsa, Oklahoma, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center
Portland, Oregon, United States
- Providence St. Vincent Medical Center
Portland, Oregon, United States
- St. Luke'S Cancer Network at St. Luke'S Hospital
Bethlehem, Pennsylvania, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Umc Southwest Cancer and Research Center
Lubbock, Texas, United States
- Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, United States
- Virginia Oncology Associates - Hampton
Hampton, Virginia, United States
- Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Morgantown, West Virginia, United States
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- 30 Jun 2008
- Completion
- 30 Jun 2008
- Last update posted
- 15 May 2013
- Registered enrollment
- 22
- Registry id
- NCT00268463
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.